Serum lipid levels in Sjögren's syndrome

Rheumatology

Volumn 45, Issue 4, 2006, Pages 481-484

  Lodde, B M ^a,b   Sankar, V ^a,c   Kok, M R ^a,b   Leakan, R A ^a   Tak, P P ^b   Pillemer, S R ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d MEDIMMUNE   (United States)

Author keywords

Cardiovascular disease; Cholesterol; HDL; Inflammation; Sj gren's syndrome

Indexed keywords

ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIBODY DETECTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL IMMUNOLOGY; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; HYPOTHESIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OPHTHALMOLOGY; PREDICTION; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; SALIVATION; SJOEGREN SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL; XEROSTOMIA;

ANTIBODIES, ANTINUCLEAR; CHOLESTEROL; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; TRIGLYCERIDES;

EID: 33645292926     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei190     Document Type: Article

References (37)

1. Svenson KL, Lithell H, Hallgren R, Selinus I, Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med 1987;147:1912-16.
2. Lakatos J, Harsagyi A. Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis. Clin Biochem 1988;21:93-6.
3. Rantapaa-Dahlqvist S, Wallberg-Jonsson S, Dahlen G. Lipo-protein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:366-8.
4. Lazarevic MB, Vitic J, Mladenovic V, Myones BL, Skosey JL, Swedler WI. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum 1992;22:172-8.
5. Park YB, Lee SK, Lee WK et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999;26:1701-4.
6. Vottery R, Saigal R, Singhal N, Gupta BS. Lipid profile in rheumatoid arthritis and its relation to disease activity. J Assoc Physicians India 2001;49:1188-90.
7. Hurt-Camejo E, Paredes S, Masana L et al. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum 2001;44:2761-7.
8. Yoo WH. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. J Rheumatol 2004;31:1746-53.
9. Dursunoglu D, Evrengul H, Polat B et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: Serum levels and relationship to inflammation. Rheumatol Int 2004;25:241-5.
10. Jacobsson LT, Turesson C, Hanson RL et al. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 2001;44:1170-6.
11. Meyer O. Atherosclerosis and connective tissue diseases. Joint Bone Spine 2001;68:564-75.
12. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology 2002;41:1095-100.
13. Moutsopoulos HM. Sjogren's syndrome: Autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-5.
14. Izumi M, Hida A, Takagi Y, Kawabe Y, Eguchi K, Nakamura T. MR imaging of the salivary glands in sicca syndrome: Comparison of lipid profiles and imaging in patients with hyperlipidemia and patients with Sjogren's syndrome. Am J Roentgenol 2000;175:829-34.
15. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
16. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10-14.
17. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97.
18. Hirsch GA, Vaid N, Blumenthal RS. Perspectives: The significance of measuring non-HDL-cholesterol. Prev Cardiol 2002;5:156-9.
19. Pertovaara M, Korpela M, Uusitalo H et al. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann Rheum Dis 1999;58:423-7.
20. Brennan MT, Sankar V, Leakan RA et al. Risk factors for positive minor salivary gland biopsy findings in Sjogren's syndrome and dry mouth patients. Arthritis Rheum 2002;47:189-95.
21. Johnson CL, Rifkind BM, Sempos CT et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. J Am Med Assoc 1993;269:3002-8.
22. Izumi M, Eguchi K, Nakamura H, Nagataki S, Nakamura T. Premature fat deposition in the salivary glands associated with Sjogren syndrome: MR and CT evidence. Am J Neuroradiol 1997;18:951-8.
23. Matsuo T, Kono R, Matsuo N et al. Incidence of ocular complications in rheumatoid arthritis and the relation of keratoconjunctivitis sicca with its systemic activity. Scand J Rheumatol 1997;26:113-16.
24. Lee YH, Choi SJ, Ji JD, Seo HS, Song GG. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 2000;19:324-5.
25. Park YB, Choi HK, Kim MY et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: A prospective study. Am J Med 2002;113:188-93.
26. Hosoai H, Webb NR, Glick JM et al. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. J Lipid Res 1999;40:648-53.
27. Dessein PH, Stanwix AE, Joffe BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: Acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002;4:R5.
28. Wallberg-Jonsson S, Cederfelt M, Rantapaa Dahlqvist S. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: An 8 year followup study. J Rheumatol 2000;27:71-5.
29. Jonsson SW, Backman C, Johnson O et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001;28:2597-602.
30. Svenson KL, Lithell H, Hallgren R, Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Intern Med 1987;147:1917-20.
31. Abud-Mendoza C, de la Fuente H, Cuevas-Orta E, Baranda L, Cruz-Rizo J, Gonzalez-Amaro R. Therapy with statins in patients with refractory rheumatic diseases: A preliminary study. Lupus 2003;12:607-11.
32. McCarey DW, McInnes IB, Madhok R et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial. Lancet 2004;363:2015-21.
33. Youssef S, Stuve O, Patarroyo JC et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002;420:78-84.
34. Leung BP, Sattar N, Crilly A et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003;170:1524-30.
35. Palmer G, Chobaz V, Talabot-Ayer D et al. Assessment of the efficacy of different statins in murine collagen-induced arthritis. Arthritis Rheum 2004;50:4051-9.
36. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
37. Moutsopoulos HM, Elkon KB, Mavridis AK, Acritidis NC, Hughes GR, Pepys MB. Serum C-reactive protein in primary Sjogren's syndrome. Clin Exp Rheumatol 1983;1:57-8.